aTyr Pharma Inc.

aTyr Pharma Inc.
Stock Exchange NASDAQ Stock Market
EPS
$13.68
Market Cap
$17.02 M
Shares Outstanding
47.21 M
Public Float
20.49 M

Profile

Address
3545 John Hopkins Court
San Diego California 92121
United States
Employees -
Website http://www.atyrpharma.com
Updated 07/08/2019
aTyr Pharma, Inc. develops protein therapeutics and novel class of biologic drugs. It plans to build a pipeline of innovative therapeutic products based on Physiocrine biology. The company has established a dominant intellectual property estate to protect the core therapeutics as well as associated diagnostics.

Financials

View All

John K. Clarke
Chairman
Sanjay Shukla
President, Chief Executive Officer & Director